Keywords: endo, buy, indevus, 370m, up, front, expand

Endo to buy Indevus for $370M up front, to expand portfolio beyond pain management

Article | 12 January 2009

Print This

Endo Pharmaceuticals has agreed to buy fellow US firm Indevus Pharmaceuticals for as much as $637.0 million, in a deal that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in